pargyline has been researched along with Diabetes Insipidus in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schöler, J | 1 |
| Sladek, JR | 1 |
| Kovács, GL | 1 |
| Szabó, G | 1 |
| Szontágh, L | 1 |
| Medve, L | 1 |
| Telegdy, G | 1 |
| László, FA | 1 |
2 other studies available for pargyline and Diabetes Insipidus
| Article | Year |
|---|---|
An altered noradrenergic innervation of the Brattleboro rat supraoptic nucleus.
Topics: Animals; Catecholamines; Diabetes Insipidus; Fluorescent Antibody Technique; Histocytochemistry; Mal | 1982 |
Hereditary diabetes insipidus in rats. Altered cerebral indolamine and catecholamine metabolism.
Topics: Animals; Brain; Diabetes Insipidus; Dopamine; Hypothalamus; Male; Mesencephalon; Methyltyrosines; No | 1980 |